Sitagliptin and Metformin hydrochloride
NDC 10370-318, sitagliptin and metformin hydrochloride, tablet, film coated, extended release, from Par Health USA, LLC.
- Product NDC
- 10370-318
- Status
- Listed
- Labeler
- Par Health USA, LLC
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204144
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10370-318 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SITAGLIPTIN PHOSPHATE50 mg/1
- METFORMIN HYDROCHLORIDE1000 mg/1
Pharmacologic classes
Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10370-318-02 | 10370031802 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (10370-318-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/43e3b1c9-3cbd-8dc3-e063-6394a90a10a2NADAC price for package 10370031802
GET /v1/drugs/nadac/10370031802
Use it
Look up 10370-318 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10370-318 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10370-318. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.